HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 321 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $251,394 | -75.3% | 6,581 | -71.5% | 0.05% | -72.5% |
| Q2 2022 | $1,016,000 | +0.7% | 23,084 | -8.7% | 0.17% | -1.7% |
| Q1 2022 | $1,009,000 | +107.6% | 25,295 | +74.1% | 0.17% | +480.0% |
| Q4 2021 | $486,000 | +1.0% | 14,526 | +22.9% | 0.03% | -67.4% |
| Q3 2021 | $481,000 | -44.0% | 11,823 | -42.6% | 0.09% | -19.3% |
| Q1 2021 | $859,000 | -38.6% | 20,593 | -37.2% | 0.11% | -37.7% |
| Q4 2020 | $1,400,000 | +6.8% | 32,782 | -34.3% | 0.18% | +9.6% |
| Q3 2020 | $1,311,000 | +498.6% | 49,879 | +511.1% | 0.17% | +496.4% |
| Q2 2020 | $219,000 | +313.2% | 8,162 | +176.0% | 0.03% | +300.0% |
| Q1 2020 | $53,000 | -92.6% | 2,957 | -92.7% | 0.01% | -94.1% |
| Q4 2019 | $719,000 | – | 40,532 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 14,092,771 | $256,066,000 | 16.64% |
| BB BIOTECH AG | 8,247,860 | $149,864,000 | 3.97% |
| MSD Partners, L.P. | 2,245,000 | $40,792,000 | 3.07% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 428,633 | $5,969,000 | 2.84% |
| First Light Asset Management, LLC | 885,523 | $16,090,000 | 2.60% |
| SNYDER CAPITAL MANAGEMENT L P | 2,387,350 | $43,378,000 | 1.93% |
| Sterling Global Strategies LLC | 22,000 | $400,000 | 1.74% |
| Taylor Wealth Management Partners | 221,380 | $4,022,000 | 1.71% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,228,399 | $167,680,000 | 1.68% |
| DOHENY ASSET MANAGEMENT /CA | 124,393 | $2,260,000 | 1.18% |